Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Acurx Pharmaceuticals Q4 EPS $(0.37) Misses $(0.26) Estimate

Author: Benzinga Newsdesk | March 18, 2024 07:04am
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.26) by 42.31 percent. This is a 32.14 percent decrease over losses of $(0.28) per share from the same period last year.

Posted In: ACXP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist